This startup develops an AI digital twin platform that simulates cancer patients to personalize therapy and anticipate relapse. The cloud-based platform helps clinicians design individualized cancer treatments and determine optimal immunotherapy, aiming to improve patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer treatment planning often relies on population-based averages, failing to account for individual patient variability in disease progression and treatment response. This can lead to suboptimal therapy selection, increased toxicity, and a higher risk of relapse for some patients. Current methods lack the ability to accurately predict individual responses to different treatment options.
Solution
GeneEra offers an AI-powered digital twin platform that simulates individual cancer patients to personalize treatment strategies and predict potential relapse. The platform constructs dynamic, real-time simulations of a patient's biology using multi-omic data, including genomics, imaging, and cellular behavior modeling. These AI Biomedical Human Twins anticipate disease progression, personalize therapies, and adapt care continuously. By simulating disease onset and progression with mechanistic precision, the platform enables clinicians to personalize therapies, prevent treatment resistance, and facilitate informed decision-making. The platform integrates AI-driven disease modeling with quantum-enhanced algorithms to analyze vast datasets and accelerate the development of targeted therapies.
Target Audience
The primary target audience includes healthcare providers, oncologists, and medical researchers seeking advanced tools for personalized cancer treatment planning and prediction of treatment outcomes. The platform also targets national health systems aiming to implement AI-driven preventative healthcare solutions.
Features
- AI-driven disease modeling for simulating disease onset and progression
- Multi-omic data integration, combining genomic, transcriptomic, proteomic, and metabolomic data
- Quantum-enhanced algorithms for biological data analysis
- AI Bio Digital Human Twins for real-time simulation of human disease
- Organ-on-a-Chip (OOC) systems for testing therapeutic approaches
- Predictive disease models for early disease detection
- Personalized therapy recommendations to prevent treatment resistance
- Continuous data integration from biomedical body and environmental sensors